Experiments using selective ROCK2 inhibitors in rodent models of kidney disease generally have preventive actions on the disease process, including reducing albuminuria and mesangial sclerosis, as well as decreasing GBM thickness. The gene discussed is ROCK2; the disease is kidney disorder.